EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Mesoblast Limited (MESO) had EBITDA Margin of -20.34% for the most recently reported fiscal year, ending 2026-06-30.
| Income Statement Financials | |
$120.25M |
|
$-57.50M |
|
$16.67M |
|
$103.58M |
|
$153.30M |
|
$-33.05M |
|
$-23.84M |
|
$-56.89M |
|
$-56.89M |
|
$-57.50M |
|
$-57.50M |
|
$-57.50M |
|
$-57.50M |
|
$-33.05M |
|
$-24.46M |
|
129.49M |
|
129.49M |
|
$-0.44 |
|
$-0.44 |
|
| Balance Sheet Financials | |
$197.49M |
|
$1.82M |
|
$575.59M |
|
$773.08M |
|
$81.11M |
|
$108.64M |
|
$123.56M |
|
$204.67M |
|
$568.41M |
|
$2.04M |
|
$568.40M |
|
129.67M |
|
| Cash Flow Statement Financials | |
$-43.83M |
|
$-1.02M |
|
$-15.33M |
|
$161.55M |
|
$102.91M |
|
$-58.64M |
|
$14.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.43 |
|
-- |
|
-- |
|
0.16 |
|
0.21 |
|
86.14% |
|
-27.48% |
|
-27.48% |
|
|
EBITDA Margin |
-20.34% |
-47.31% |
|
-47.82% |
|
$-44.66M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.59 |
|
2.09 |
|
175.02 |
|
-10.12% |
|
-2825.59% |
|
-7.44% |
|
-8.49% |
|
$4.38 |
|
$-0.34 |
|
$-0.34 |
|